mTOR Inhibitors in Autosomal Dominant Polycystic Kidney Disease
Medscape The mean adherence to sirolimus was calculated to be 97% of the correct dose. Most patients were in chronic kidney disease (CKD) stage 1 or 2 (94% for … |
mTOR Inhibitors in Autosomal Dominant Polycystic Kidney Disease
Medscape The mean adherence to sirolimus was calculated to be 97% of the correct dose. Most patients were in chronic kidney disease (CKD) stage 1 or 2 (94% for … |